Fig. 1From: Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trialFlow chart. *One patient was excluded from the analysis due to incorrect inclusion (renal replacement therapy). **Two patients were excluded from the analysis due to incorrect inclusion (renal replacement therapy and previous use of meropenem). GNB: gram-negative bacilli; CABP: community-acquired bacterial pneumonia; HIV/AIDS: human immunodeficiency virus infection and acquired immune deficiency syndrome; CPIS: Clinical Pulmonary Infection Score; VAP: ventilator-associated pneumoniaBack to article page